SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039831
Filing Date
2023-08-08
Accepted
2023-08-08 16:15:59
Documents
68
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pstx-20230630.htm   iXBRL 10-Q 2930536
2 EX-10.1 pstx-ex10_1.htm EX-10.1 152036
3 EX-31.1 pstx-ex31_1.htm EX-31.1 16640
4 EX-31.2 pstx-ex31_2.htm EX-31.2 16639
5 EX-32.1 pstx-ex32_1.htm EX-32.1 11251
6 EX-32.2 pstx-ex32_2.htm EX-32.2 11275
  Complete submission text file 0000950170-23-039831.txt   9308083

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pstx-20230630_lab.xml EX-101.LAB 476584
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pstx-20230630_cal.xml EX-101.CAL 44979
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pstx-20230630_pre.xml EX-101.PRE 343748
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pstx-20230630_def.xml EX-101.DEF 202571
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pstx-20230630.xsd EX-101.SCH 54505
62 EXTRACTED XBRL INSTANCE DOCUMENT pstx-20230630_htm.xml XML 1496446
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39376 | Film No.: 231151552
SIC: 2836 Biological Products, (No Diagnostic Substances)